Zpráva o průběhu klinického hodnocení KDO_DC1311 (EudraCT č. 2014-003388-39) za období od 10.09.2021 do 09.09.2022

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Annual report about the clinical trial KDO_DC1311 (EudraCT No. 2014-003388-39) for the period from 10 Sept 2021 to 09 Sept 2022
Authors

DEMLOVÁ Regina KUBÁTOVÁ Jana

Year of publication 2022
MU Faculty or unit

Faculty of Medicine

Web KDO_DC1311
Description The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info